Literature DB >> 2494666

Isotype switching by a microinjected mu immunoglobulin heavy chain gene in transgenic mice.

J Durdik1, R M Gerstein, S Rath, P F Robbins, A Nisonoff, E Selsing.   

Abstract

Immunization of transgenic mice carrying an immunoglobulin mu heavy chain resulted in a response dominated by expression of the transgene variable region. Unexpectedly, in a large proportion of the antibody produced by immunized mice, the transgene variable region was associated with IgG rather than IgM. This demonstrates that the transgene can undergo an isotype switch. Four transgenic founder lines all exhibited transgene isotype switching despite the likelihood of random chromosomal integration of the transgene. In addition one of the lines was analyzed by breeding studies and the transgene was found to be genetically unlinked to the immunoglobulin heavy chain (Igh) locus. These results indicate that a precise chromosomal location is not required for isotype switching and suggest the possibility that the isotype switching process can occur interchromosomally.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2494666      PMCID: PMC286909          DOI: 10.1073/pnas.86.7.2346

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Complete sequence of constant and 3' noncoding regions of an immunoglobulin mRNA using the dideoxynucleotide method of RNA sequencing.

Authors:  P H Hamlyn; G G Browniee; C C Cheng; M J Gait; C Milstein
Journal:  Cell       Date:  1978-11       Impact factor: 41.582

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  Molecular analysis of heavy and light chains used by primary and secondary anti-(T,G)-A--L antibodies produced by normal and xid mice.

Authors:  P Busto; R Gerstein; L Dupre; C A Giorgetti; E Selsing; J L Press
Journal:  J Immunol       Date:  1987-07-15       Impact factor: 5.422

4.  Segregation at a locus determining an immunoglobulin genetic marker for the light chain variable region affects inheritance of expression of an idiotype.

Authors:  J A Laskin; A Gray; A Nisonoff; N R Klinman; P D Gottlieb
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

5.  Deletions are associated with somatic rearrangement of immunoglobulin heavy chain genes.

Authors:  S Cory; J M Adams
Journal:  Cell       Date:  1980-01       Impact factor: 41.582

6.  Rearrangement of immunoglobulin gamma 1-chain gene and mechanism for heavy-chain class switch.

Authors:  T Kataoka; T Kawakami; N Takahashi; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

7.  Recombinant rabbit secretory immunoglobulin molecules: alpha chains with maternal (paternal) variable-region allotypes and paternal (maternal) constant-region allotypes.

Authors:  K L Knight; T R Malek; W C Hanly
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

8.  The role of gene deletion in the immunoglobulin heavy chain switch.

Authors:  T H Rabbitts; A Forster; W Dunnick; D L Bentley
Journal:  Nature       Date:  1980-01-24       Impact factor: 49.962

9.  Suppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes.

Authors:  Y Dohi; A Nisonoff
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

10.  Quantitative investigations of idiotypic antibodies. VI. Idiotypic specificity as a potential genetic marker for the variable regions of mouse immunoglobulin polypeptide chains.

Authors:  M G Kuettner; A L Wang; A Nisonoff
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  26 in total

1.  Silent development of memory progenitor B cells.

Authors:  Katja Aviszus; Xianghua Zhang; Lawrence J Wysocki
Journal:  J Immunol       Date:  2007-10-15       Impact factor: 5.422

Review 2.  The molecular basis of immunoglobulin class switching: switch transcription versus switch recombination.

Authors:  A Radbruch
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

Review 3.  Regulation of IgE production and other immunopathogenetic mechanisms.

Authors:  B A Chowdhury
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

4.  Immunoglobulin double-isotype expression by trans-mRNA in a human immunoglobulin transgenic mouse.

Authors:  A Shimizu; M C Nussenzweig; T R Mizuta; P Leder; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  A well-differentiated B-cell line is permissive for somatic mutation of a transfected immunoglobulin heavy-chain gene.

Authors:  M Zhu; J L Rabinowitz; N S Green; B J Kobrin; M D Scharff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 6.  Regulation of IgE synthesis: from the membrane to the genes.

Authors:  D Vercelli; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1993

7.  The role of germline promoters and I exons in cytokine-induced gene-specific class switch recombination.

Authors:  Wesley A Dunnick; Jian Shi; Victoria Holden; Clinton Fontaine; John T Collins
Journal:  J Immunol       Date:  2010-12-03       Impact factor: 5.422

8.  Mutation in a reporter gene depends on proximity to and transcription of immunoglobulin variable transgenes.

Authors:  A Umar; P A Schweitzer; N S Levy; J D Gearhart; P J Gearhart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

9.  Anomalous rearrangements of the immunoglobulin heavy chain genes in human leukemias support the loop-out mechanism of class switch.

Authors:  M Laffan; L Luzzatto
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

10.  Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region.

Authors:  Wesley A Dunnick; John T Collins; Jian Shi; Gerwin Westfield; Clinton Fontaine; Paul Hakimpour; F Nina Papavasiliou
Journal:  J Exp Med       Date:  2009-11-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.